These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 25659761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.
    Kirchner GI, Scherer MN, Obed A, Ruemmele P, Wiest R, Froh M, Loss M, Schlitt HJ, Schölmerich J, Gelbmann CM.
    Scand J Gastroenterol; 2011 Apr; 46(4):471-8. PubMed ID: 21114429
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biliary candida infections in primary sclerosing cholangitis.
    Kulaksiz H, Rudolph G, Kloeters-Plachky P, Sauer P, Geiss H, Stiehl A.
    J Hepatol; 2006 Nov; 45(5):711-6. PubMed ID: 16979779
    [Abstract] [Full Text] [Related]

  • 5. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
    Kim JH, Byun JH, Kim SY, Lee SS, Kim HJ, Kim MH, Lee MG.
    Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
    Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO.
    Endoscopy; 2012 Nov; 44(11):1055-8. PubMed ID: 23108773
    [Abstract] [Full Text] [Related]

  • 8. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
    Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Hetzer R, Schaffartzik W, Tryba M, Neuhaus P, Seehofer D.
    Crit Care; 2015 Mar 31; 19(1):131. PubMed ID: 25886728
    [Abstract] [Full Text] [Related]

  • 9. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.
    Rupp C, Friedrich K, Folseraas T, Wannhoff A, Bode KA, Weiss KH, Schirmacher P, Sauer P, Stremmel W, Gotthardt DN.
    Aliment Pharmacol Ther; 2014 Apr 31; 39(8):873-82. PubMed ID: 24612312
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
    Voigtländer T, Jaeckel E, Lehner F, Manns MP, Lankisch TO.
    Liver Transpl; 2015 Oct 31; 21(10):1295-9. PubMed ID: 26069199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM, Rümmele P, Wimmer M, Hofstädter F, Göhlmann B, Endlicher E, Kullmann F, Langgartner J, Schölmerich J.
    Am J Gastroenterol; 2007 Jun 31; 102(6):1221-9. PubMed ID: 17531010
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S, Jürgensen C, Frohme J, Grajecki D, Adler A, Sigal M, Leonhardt J, Voll JM, Kruse JM, Körner R, Eckardt KU, Janssen HJ, Gebhardt V, Schmittner MD, Pa-COVID-19 collaborative study group, Frey C, Müller-Ide H, Bauer M, Thibeault C, Kurth F, Sander LE, Müller T, Tacke F.
    Hepatol Int; 2023 Dec 31; 17(6):1610-1625. PubMed ID: 37119516
    [Abstract] [Full Text] [Related]

  • 18. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis.
    Pohl J, Ring A, Stremmel W, Stiehl A.
    Eur J Gastroenterol Hepatol; 2006 Jan 31; 18(1):69-74. PubMed ID: 16357622
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C.
    Gut; 2020 Apr 31; 69(4):665-672. PubMed ID: 31243055
    [Abstract] [Full Text] [Related]

  • 20. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    Pereira P, Aho V, Arola J, Boyd S, Jokelainen K, Paulin L, Auvinen P, Färkkilä M.
    PLoS One; 2017 Apr 31; 12(8):e0182924. PubMed ID: 28796833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.